5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Cardiac Catheterization
Cardiac catheterization is considered a minimally invasive procedure compared to traditional open-heart surgery, providing valuable diagnostic information with a relatively low risk of complications. It is an essential tool in the field of interventional cardiology, enabling precise and targeted treatments for coronary artery disease. In cases where significant blockages are identified, angioplasty may be performed to widen narrowed arteries, and stents may be inserted to help maintain the vessel's patency. The procedure is typically conducted in a specialized cardiac catheterization laboratory (cath lab) by a skilled team of interventional cardiologists and supporting healthcare professionals. Cardiac catheterization plays a pivotal role in guiding treatment decisions, improving patient outcomes, and contributing to advancements in the understanding and management of cardiovascular diseases.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain